Description
A lichen metabolite with antioxidant, anticancer, antifungal, antiprotozoal, and antimicrobial activities; reduces the number of indomethacin-induced gastric ulcers in rats through decreased lipid peroxidation and decreased myeloperoxidase activity; fungicidal against C. orthopsilosis and C. parapsilosis (IC80s = 7.8 and 15.6 μg/ml, respectively); bactericidal against vancomycin-resistant E. faecalis (MIC = 125 μg/ml); reduces L. amazonensis parasite loads by 72.3% in footpads of infected mice; reduces growth of cancer cells in vitro (IC50s = 48.5-199 μM),
Formal name: 2,6-diacetyl-7,9-dihydroxy-8,9b-dimethyl-1,3(2H,9bH)-dibenzofurandione
Synonyms: NSC 8517
Molecular weight: 344.3
CAS: 125-46-2
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Antibiotics||Product Type|Biochemicals|Antifungals||Product Type|Biochemicals|Antiparasitics|Antiprotozoals||Product Type|Biochemicals|Ox Stress Reagents|Antioxidants||Research Area|Cancer||Research Area|Immunology & Inflammation|Gastric Disease|Peptic Ulcers||Research Area|Infectious Disease|Bacterial Diseases||Research Area|Infectious Disease|Fungal Diseases||Research Area|Infectious Disease|Parasitic Diseases|Leishmaniasis